| Rivaroxaban (Xarelto®) | Dalteparin Sodium (Fragmin®) | p-value |
Patients, n | 150 | 150 |
|
Age, yr (range) | 68.7 (51 - 88) | 69.6 (58 - 86) | 0.280 |
Gender, M:F | 16:134 | 22:128 | 0.298 |
BMIa, kg/m2 (range) | 26.2 (17 - 37) | 26.1 (14 - 34) | 0.940 |
Unilateral TKA, n (P/Cb) | 51 (34.0%) | 105 (70.0%) | 0.513 |
Bilateral TKA, n (P/Cb) | 99 (66.0%) | 45 (30.0%) | |
Diabetes, n (P/Cb) | 33 (22.0%) | 33 (22.0%) | 1.000 |
Hypertension, n (P/Cb) | 102 (67.3%) | 99 (66.0%) | 0.713 |
Hyperlipidemia, n (P/Cb) | 46 (30.7%) | 38 (25.3%) | 0.304 |
Smoking, n (P/Cb) | 1 (0.7%) | 1 (0.7%) | 1.000 |
History of lower limb surgery, n (P/Cb) | 35 (23.3%) | 36 (24%) | 0.491 |